+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction



Efficacy of clopidrogel on reperfusion and high-sensitivity C-reactive protein in patients with acute myocardial infarction



Mediators of Inflammation 2009: 932515



We investigated the effects of clopidogrel on reperfusion and inflammatory process in STEMI. A total of 175 STEMI patients with similar clinical characteristics were included to this study. One was the standard pharmacological reperfusion therapy group (group 1, n : 90), who received 300 mg aspirin, 70 U/kg bolus, and 12 U/kg/hr continuous infusion of unfractioned heparin and accelerated t-PA. Clopidogrel 450 mg loading and 75 mg/d thereafter was added to standard reperfusion therapy in the other group (group 2, n : 85). The ST-segment resolution, CK-MB, and high-sensitive CRP (hs-CRP) parameters were measured. Complete ST resolution was observed in 32 patients (36.8%) in group 1 and 53 patients (63.8%) in group 2 (P < .001). Also in the first 24 hours, the CK-MB levels of patients in group 1 were significantly higher than those of group 2 (P = .001). The hs-CRP values were greater in group 1 than group 2 at 48th hour (group 1: 9.4 +/- 0.1 mg/L, group 2: 3.7 +/- 1.4 mg/L; P = .000). We concluded that adding clopidogrel to standard treatment in STEMI patients provided early reperfusion and suppression of inflammatory response.

(PDF emailed within 0-6 h: $19.90)

Accession: 052900607

Download citation: RISBibTeXText

PMID: 19365587

DOI: 10.1155/2009/932515


Related references

Impact of high-sensitivity C-reactive protein on long-term mortality of acute myocardial infarction in the reperfusion era. Journal of the American College of Cardiology 41(6 Supplement A): 324A-325A, March 19, 2003

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. American Journal of Cardiology 89(2): 145-149, January 15, 2002

The relationship between high sensitivity C-reactive protein level at admission and myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Zhonghua Xin Xue Guan Bing Za Zhi 34(5): 422-424, 2006

High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction. Heart and Vessels 18(2): 67-74, 2003

Concomitant impact of high-sensitivity C-reactive protein and renal dysfunction in patients with acute myocardial infarction. Yonsei Medical Journal 55(1): 132-140, 2014

Comparison of high-sensitivity C-reactive protein level between systemic and coronary circulation in patients with acute myocardial infarction. Acta Biochimica et Biophysica Sinica 46(2): 161-162, 2014

Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. International Journal of Cardiology 167(5): 1848-1853, 2014

Prognostic Value of High-Sensitivity C-Reactive Protein and Lipoprotein a in Acute Myocardial Infarction Patients Receiving Emergency Percutaneous Coronary Intervention. Journal of Medical Biochemistry 31(2), 2012

Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 127(3): 803-808, 2005

Do baseline C-reactive protein levels predict myocardial salvage after reperfusion therapy in patients with acute myocardial infarction?. Journal of the American College of Cardiology 41(6 Supplement A): 348A, March 19, 2003

High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction. International Journal of Cardiology 248: 51-56, 2017

The Relationship among N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein and Infarct Size in Patients with Acute ST-Elevation Myocardial Infarction. Korean Circulation Journal 45(4): 285-293, 2015

Clinical impacts of high-sensitivity C-reactive protein reduction for secondary prevention in Asian patients with one-year survivor after acute myocardial infarction. International Journal of Cardiology 193: 20-22, 2016

Effect of statin treatment in patients with acute myocardial infarction and left ventricular systolic dysfunction according to the level of high-sensitivity C-reactive protein. International Heart Journal 55(2): 106-112, 2014

Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. European Heart Journal 24(12): 1128-1133, 2003